Product synthetic-chemistry-protein-crosslinkers

Home > products > synthetic-chemistry> protein-crosslinkers

Catalog	name	Description	price
R-R-0277	Easily-Eluted Protein G, ee-ProG	Easily-eluted Protein G/ee-ProG refers to a specific variant or form of Protein G that is designed to be easily separated or eluted from a purification system. Easily-eluted Protein G variants or forms are especially useful in applications where the requirement for high purity and integrity of the target proteins is crucial. This includes antibody purification, protein-protein interaction studies, and other downstream applications where gentle elution conditions are preferred to preserve the biological activity of the purified proteins.	price>
R-R-0278	Recombinant Human Epidermal, rh-EGF	Recombinant Human Epidermal Growth Factor, or recombinant hEGF, is a biotechnology-derived form of the naturally occurring human Epidermal Growth Factor (EGF).Recombinant hEGF is produced through genetic engineering techniques, where the DNA sequence encoding the human EGF protein is inserted into an expression system, such as bacteria, yeast, or mammalian cells. This allows for the production of large quantities of the protein in a controlled manner.	price>
R-R-0279	Recombinant Human Growth, rh-GH	Recombinant Human Growth Hormone, or recombinant hGH, is a biotechnology-derived form of the naturally occurring human Growth Hormone (GH). Recombinant hGH has been extensively used in medical and therapeutic applications, especially in the treatment of growth disorders. It is used to supplement or replace the naturally occurring GH in individuals who have deficiencies or inadequate GH production, such as those with growth hormone deficiency (GHD), Turner syndrome, or chronic renal insufficiency. Treatment with recombinant hGH can help stimulate growth and improve height in these individuals.	price>
R-R-0280	Streptavidin Conjugated with Horseradish, SA-HRP	Streptavidin conjugated with horseradish peroxidase (HRP) is a commonly used reagent in biochemistry and molecular biology. By utilizing streptavidin conjugated with HRP, researchers can generate highly specific and sensitive detection systems for various applications, including protein and nucleic acid detection.	price>
R-R-0281	Recombinant BirA Biotin Ligase-CBD-tag, rC-BirA	Recombinant BirA Biotin Ligase, CBD-tag is a biotechnology-derived enzyme that is used in molecular biology and protein labeling applications.When the recombinant BirA Biotin Ligase, CBD-tag is used in protein labeling applications, the ligase binds specifically to the CBD-tag engineered onto the target protein. In the presence of biotin and ATP, the BirA ligase catalyzes the transfer of biotin onto a specific lysine residue within the CBD-tag, resulting in the covalent attachment of biotin to the target protein.	price>
R-R-0289	NH2-FAPI-4	NH2-FAPI-4 is a specific type of fibroblast activation protein inhibitor (FAPI).NH2-FAPI-4 is one of the FAPI derivatives designed to have higher stability and more favorable pharmacokinetic properties compared to earlier FAPI compounds. It has shown promising results in preclinical studies, demonstrating its ability to selectively accumulate in FAP-positive tumors and effectively inhibit FAP activity.	price>
R-R-0290	FAPI-05	FAPI-05/Fibroblast-activation-protein inhibitor-5 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer.	price>
R-R-0291	FAPI-06	FAPI-06/Fibroblast-activation-protein inhibitor-6 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer.	price>
R-R-0292	FAPI-07	FAPI-07/Fibroblast-activation-protein inhibitor-7 from ruixi. FAPI compounds are a class of small molecule inhibitors designed to target fibroblast activation protein (FAP), an enzyme overexpressed in the tumor microenvironment of certain cancers. These inhibitors have shown promise in preclinical studies for their ability to selectively accumulate in FAP-positive tumors and disrupt the tumor-promoting functions of cancer-associated fibroblasts (CAFs).	price>
R-R-0293	FAPI-08	FAPI-08/Fibroblast-activation-protein inhibitor-8 is a small molecule compound designed to target fibroblast activation protein (FAP), an enzyme that is overexpressed in the tumor microenvironment of various cancers, including pancreatic, colorectal, lung, and breast cancer.	price>

...